These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 3905162)

  • 1. Associated non-ovarian problems of polycystic ovarian disease: insulin resistance.
    Chang RJ; Geffner ME
    Clin Obstet Gynaecol; 1985 Sep; 12(3):675-85. PubMed ID: 3905162
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Insulin resistance in polycystic ovary syndrome.
    Prelevic GM
    Curr Opin Obstet Gynecol; 1997 Jun; 9(3):193-201. PubMed ID: 9263704
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hyperandrogenism, insulin resistance and acanthosis nigricans. 10 years of progress.
    Barbieri RL
    J Reprod Med; 1994 May; 39(5):327-36. PubMed ID: 8064699
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Hyperinsulinism and insulin resistance in the polycystic ovary syndrome as tested with tolbutamide].
    Matteini M; Cotrozzi G; Bufalini GN; Relli P; Lazzari T
    Boll Soc Ital Biol Sper; 1982 Nov; 58(22):1455-60. PubMed ID: 6762218
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insulin levels and 125I-insulin binding to monocytes in a non obese pregnant woman with polycystic ovarian disease.
    Mahabeer S; Norman RJ
    Diabetes Res; 1990 Aug; 14(4):197-200. PubMed ID: 2132194
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Oral glucose tolerance test in polycystic ovary syndrome].
    Cotrozzi G; Matteini M; Relli P; Lazzari T; Bufalini GN
    Boll Soc Ital Biol Sper; 1982 Nov; 58(22):1446-50. PubMed ID: 6762216
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adiponectin levels in women with polycystic ovary syndrome and severe insulin resistance.
    Sepilian V; Nagamani M
    J Soc Gynecol Investig; 2005 Feb; 12(2):129-34. PubMed ID: 15695109
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Obesity, weight loss, and the polycystic ovary syndrome: effect of treatment with diet and orlistat for 24 weeks on insulin resistance and androgen levels.
    Panidis D; Farmakiotis D; Rousso D; Kourtis A; Katsikis I; Krassas G
    Fertil Steril; 2008 Apr; 89(4):899-906. PubMed ID: 17980364
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Hyperinsulinemia and disorders of the menstrual cycle].
    Dravecká I; Lazúrová I; Kraus V; Petrovicová J; Paĺko M
    Vnitr Lek; 2002 Mar; 48(3):192-6. PubMed ID: 11968579
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of clinical characteristics in large-scale Chinese women with polycystic ovary syndrome.
    Shi Y; Guo M; Yan J; Sun W; Zhang X; Geng L; Xu L; Chen Z
    Neuro Endocrinol Lett; 2007 Dec; 28(6):807-10. PubMed ID: 18063948
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma metastin levels are negatively correlated with insulin resistance and free androgens in women with polycystic ovary syndrome.
    Panidis D; Rousso D; Koliakos G; Kourtis A; Katsikis I; Farmakiotis D; Votsi E; Diamanti-Kandarakis E
    Fertil Steril; 2006 Jun; 85(6):1778-83. PubMed ID: 16650418
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Are polycystic ovaries associated with cardiovascular disease risk as polycystic ovary syndrome?
    Engin-Ustün Y; Ustün Y; Meydanli MM; Kafkasli A; Yetkin G
    Gynecol Endocrinol; 2006 Jun; 22(6):324-8. PubMed ID: 16785157
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Insulin resistance in polycystic ovary syndrome].
    Aquino Carlos P; Hernández Valencia M
    Ginecol Obstet Mex; 1998 Nov; 66():446-51. PubMed ID: 9823701
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overnight secretion pattern of growth hormone, sex hormone binding globulin, insulin-like growth factor-1 and its binding protein in obese and non-obese women with polycystic ovarian disease.
    Insler V; Barash A; Shoham Z; Koistinen R; Seppala M; Hen M; Lunenfeld B; Zadik Z
    Isr J Med Sci; 1994 Jan; 30(1):42-7. PubMed ID: 7511134
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of ovarian functionality after a dietary treatment in obese women with polycystic ovary syndrome.
    Tolino A; Gambardella V; Caccavale C; D'Ettore A; Giannotti F; D'Antò V; De Falco CL
    Eur J Obstet Gynecol Reprod Biol; 2005 Mar; 119(1):87-93. PubMed ID: 15734091
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolic characteristics of women with polycystic ovaries and oligo-amenorrhoea but normal androgen levels: implications for the management of polycystic ovary syndrome.
    Barber TM; Wass JA; McCarthy MI; Franks S
    Clin Endocrinol (Oxf); 2007 Apr; 66(4):513-7. PubMed ID: 17371468
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Polycystic ovary syndrome: pathophysiology, molecular aspects and clinical implications.
    Nardo LG; Patchava S; Laing I
    Panminerva Med; 2008 Dec; 50(4):267-78. PubMed ID: 19078868
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effect of long-term treatment with metformin on steroid levels and parameters of insulin resistance in women with polycystic ovary syndrome].
    Vrbíková J; Hill M; Stárka L; Cibula D; Snajderová M; Sulcová J; Vondra K; Bendlová B
    Cas Lek Cesk; 2001 Nov; 140(22):688-94. PubMed ID: 11789058
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Body fat composition and distribution in women with polycystic ovary syndrome.
    Cosar E; Uçok K; Akgün L; Köken G; Sahin FK; Arioz DT; Baş O
    Gynecol Endocrinol; 2008 Aug; 24(8):428-32. PubMed ID: 18850379
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hyperinsulinemia does not influence androgens/estrogens ratio in patients with polycystic ovarian syndrome.
    Panidis DK; Rousso DH; Matalliotakis IM; Kourtis AI; Vlassis GD; Koumantakis EE
    Int J Fertil Womens Med; 1999; 44(6):301-6. PubMed ID: 10617252
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.